Whipple Procedure(Pancreaticoduodenectomy) for Pancreatic and Periampullary Cancers

The pancreas is a gland located behind the stomach, with its head nestled in the loop of the duodenum. It lies close to major blood vessels, including the superior mesenteric vessels, portal vein, hepatic artery and celiac axis. The pancreas is divided into three parts: the head, body and tail.

The thin tube carrying bile from the liver (bile duct) joins the tube bringing pancreatic juice (pancreatic duct) in the head of the pancreas and opens into the duodenum.

The pancreas has two main functions: producing digestive enzymes for food breakdown, and hormones like insulin and glucagon that regulate blood sugar levels.

Periampullary cancers develop in or around the ampulla of Vater, the region where the bile duct and pancreatic duct join and empty into the duodenum. This group includes cancers of the pancreatic head, distal bile duct (cholangiocarcinoma), ampulla and the adjacent duodenum.

When pancreatic or periampullary cancers are detected before they have spread to other organs, surgery offers the best chance of cure. Complete surgical removal of the tumour remains the most effective treatment in such cases.

For cancers of the pancreatic head and other periampullary tumours, the Whipple procedure (pancreaticoduodenectomy) is the standard surgical operation. In contrast, tumours arising in the body or tail of the pancreas are usually treated with a distal pancreatectomy.

Whipple procedure or pancreaticoduodenectomy is a complex surgical procedure. This operation is named after Allen Whipple, who was the first surgeon to perform this operation in 1935.

Before undergoing the Whipple procedure, patients undergo a comprehensive evaluation to determine the extent of the disease, assess overall fitness for surgery, and identify any factors that may affect treatment planning.

This evaluation typically includes:

• Pancreatic-protocol contrast CT scan with integrated PET
• Blood tests including complete blood count, liver and kidney function, and coagulation profile
• Tumour marker assessment such as CA 19-9
• Nutritional assessment and anaesthetic fitness evaluation
• Biopsy in selected cases
• Review in a multidisciplinary tumour board

1. Stage 1: tumour removal
   The tumour and involved structures are removed.
2. Stage 2: reconstruction
   The digestive system is reconstructed to restore its continuity.

It is a complex operation that typically takes several hours and requires significant surgical expertise. The anatomy is intricate, with important blood vessels closely surrounding the pancreas and natural variations in their arrangement. In some cases, the tumour may involve these vessels, requiring careful dissection or vascular resection and reconstruction of structures such as the portal vein, superior mesenteric vein or hepatic artery to achieve complete tumour removal.

After the tumour and involved structures are removed, the digestive system is reconstructed by creating three main connections:

1. Pancreaticojejunostomy (or pancreaticogastrostomy): the remaining pancreas is connected to the small intestine or, in selected cases, to the stomach.
2. Hepaticojejunostomy: the bile duct is connected to the small intestine.
3. Gastrojejunostomy: the stomach is connected to the small intestine.

Whipple procedure anatomy

What Is Removed During a Whipple Procedure?

Depending on the type of Whipple procedure, the surgeon generally removes:

• Head of the pancreas
• Duodenum (first part of the small intestine)
• Gallbladder
• Lower part of the bile duct
• Nearby lymph nodes
• Sometimes part of the stomach (in standard Whipple)

In a pylorus-preserving Whipple (PPPD), the stomach and pylorus are preserved.

Whipple Operation or Pancreaticoduodenectomy: Structures colored blue is removed in whipple procedure.

Whipple Operation or Pancreaticoduodenectomy: Reconstruction.

Not all patients with pancreatic or periampullary cancer are suitable for Whipple surgery. Patients are generally classified as:

• Resectable: the tumour can be completely removed with clear margins and without major blood vessel involvement.
• Borderline resectable / locally advanced: the tumour is close to or involving nearby blood vessels. Chemotherapy is usually given first to shrink the tumour and improve the chance of complete removal, followed by surgery if it responds well.
• Metastatic: the cancer has spread to distant organs, and surgery is usually not beneficial.

For surgery to be possible, the disease should be confined to the pancreas and nearby structures, without spread to distant organs such as the liver, lungs or peritoneum, and without unreconstructable involvement of major blood vessels.

Patient fitness is equally important, including adequate heart, lung and nutritional reserve to tolerate a major operation.

In selected patients with significant jaundice, cholangitis, or as part of planned neoadjuvant (preoperative) treatment, bile drainage may be required before surgery, usually via an endoscopic procedure called ERCP (Endoscopic Retrograde Cholangiopancreatography). During ERCP, a plastic or metal stent may be placed in the bile duct to relieve obstruction and improve liver function before treatment.

A multidisciplinary pancreatic cancer team reviews all scans and clinical details to decide the best treatment plan, including whether surgery should be done upfront or after preoperative therapy.

Since it is a complex operation, your surgeon should have done enough of them. A high volume pancreatic surgeon performs more than 15 to 20 such surgeries per year. A high volume surgeon at a high volume centre will have the best outcome. For the success of a surgical procedure, it is not only important for the surgeon to be skilled, but also for the rest of the medical team and the hospital infrastructure to be well-equipped.

Pancreatic cancer surgery is complex and is most commonly performed as open surgery, where a single large abdominal incision is used to access and remove the tumour.

The robotic Whipple procedure is a minimally invasive alternative that performs the same operation through several small incisions using robotic instruments.

A 3D high-definition camera provides magnified vision, while the surgeon operates from a console controlling robotic arms with wristed instruments that can rotate and bend beyond the human hand, allowing precise work in deep abdominal spaces with improved stability and meticulous suturing during reconstruction.

Robotic surgery uses smaller incisions and may reduce postoperative pain, blood loss, and recovery time. When performed by experienced surgeons in appropriately selected cases, it can achieve oncological outcomes comparable to open surgery. However, it is a highly specialised approach and is not suitable for all patients, and is typically considered only in selected cases depending on tumour location, stage, vascular involvement, and overall surgical feasibility.

Regardless of the approach, the goal remains the same: complete and safe cancer removal with the best possible oncological outcome.

Hospital recovery commonly takes around one to two weeks, although the stay may be longer if complications occur. During the initial recovery, patients are monitored for pain, bleeding, infection, pancreatic or bile leakage, bowel function and nutrition.

At the time of discharge, most patients are eating a light, easy-to-digest diet and can perform daily activities with support, although strength and stamina remain reduced. Appetite, weight, bowel habits and energy levels continue to improve gradually over the following weeks, and some patients may require pancreatic enzyme replacement therapy or dietary adjustments during recovery.

After recovery from surgery, many patients are advised adjuvant treatment, which may include chemotherapy (and in selected cases radiotherapy), to reduce the risk of cancer recurrence. The exact treatment plan depends on the final pathology report, lymph node status, margin status and overall fitness.

Recovery varies considerably between patients and depends on the operation, complications and overall health.

Whipple surgery is a major operation and can have complications, even in experienced centres. Important complications include:

• Pancreatic fistula or pancreatic leak
• Delayed gastric emptying
• Bleeding
• Bile leakage
• Abdominal or wound infection
• Blood clots or chest infection
• Nutritional difficulties or pancreatic enzyme insufficiency
• New or worsening diabetes
• Occasionally, the need for drainage, endoscopy, radiological treatment or another operation

The risk varies according to the patient's health, tumour type, pancreatic texture, complexity of surgery and experience of the treating centre.

Outcomes after Whipple surgery are best understood in two parts: short-term surgical success and long-term cancer outcomes.

Short-Term Outcomes (Operative Success and Recovery)

Whipple surgery is a complex operation, but in experienced centres it is now performed with a high rate of successful completion and recovery.

Long-Term Outcomes (Cancer Control and Survival)

Long-term results depend primarily on the type and stage of cancer, lymph node involvement, tumour biology, and whether the tumour has been completely removed. There is no single "success rate" for Whipple surgery, as it is performed for different cancers with varying behaviour, so long-term survival varies accordingly.

• Ampullary and duodenal cancers: approximately 55-60% five-year survival after surgery in appropriately selected patients
• Pancreatic cancer and distal bile duct cancer: approximately 35-45% five-year survival after surgery in selected patients

For appropriately selected patients, the Whipple procedure is the only potentially curative treatment and offers the best chance for long-term disease control and, in some cases, potential cure.